Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 3, 2021 FORM 4 SUBMISSION
4 Jun 3, 2021 FORM 4 SUBMISSION
4 Jun 3, 2021 FORM 4 SUBMISSION
4 Jun 3, 2021 FORM 4 SUBMISSION
4 Jun 3, 2021 FORM 4 SUBMISSION
4 Jun 3, 2021 FORM 4 SUBMISSION
4 Jun 3, 2021 FORM 4 SUBMISSION
4 Jun 3, 2021 FORM 4 SUBMISSION
8-K May 27, 2021 8-K
4/A May 17, 2021 FORM 4/A SUBMISSION
SC 13G May 14, 2021
8-K May 12, 2021 8-K
10-Q May 6, 2021 10-Q
8-K May 6, 2021 8-K
DEFA14A Apr 21, 2021 DEFA14A
DEF 14A Apr 21, 2021 DEF 14A
4 Apr 20, 2021 FORM 4 SUBMISSION
3 Apr 20, 2021 FORM 3 SUBMISSION
S-8 Mar 3, 2021 S-8
10-K Mar 3, 2021 10-K
8-K Mar 3, 2021 8-K
SC 13D/A Feb 17, 2021 AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP
4 Feb 16, 2021 FORM 4 SUBMISSION
4 Feb 16, 2021 FORM 4 SUBMISSION
4 Feb 16, 2021 FORM 4 SUBMISSION
← Newer Page 18 of 27 · 661 filings Older →